"The
Report Ischemia Reperfusion Injury - Pipeline Review, H2 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Global Markets Directs,
Ischemia
Reperfusion Injury
- Pipeline Review, H2 2016, provides an overview of the Ischemia
Reperfusion Injury pipeline landscape.
The report provides
comprehensive information on the therapeutics under development for
Ischemia Reperfusion Injury, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Ischemia Reperfusion Injury and
features dormant and discontinued projects.
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/804927
Scope
- The report provides a
snapshot of the global therapeutic landscape of Ischemia Reperfusion
Injury
- The report reviews pipeline
therapeutics for Ischemia Reperfusion Injury by companies and
universities/research institutes based on information derived from
company and industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features
descriptive drug profiles for the pipeline products which includes,
product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key
players involved Ischemia Reperfusion Injury therapeutics and enlists
all their major and minor projects
- The report assesses Ischemia
Reperfusion Injury therapeutics based on drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest
news related to pipeline therapeutics for Ischemia Reperfusion Injury
Reasons to buy
- Gain strategically
significant competitor information, analysis, and insights to
formulate effective R&D strategies
- Identify emerging players
with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand
important and diverse types of therapeutics under development for
Ischemia Reperfusion Injury
- Identify potential new
clients or partners in the target demographic
- Develop strategic initiatives
by understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures
for pipeline projects by understanding Ischemia Reperfusion Injury
pipeline depth and focus of Indication therapeutics
- Develop and design
in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand
business potential and scope
- Modify the therapeutic
portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline
Table
of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 7
Global Markets Direct Report
Coverage 7
Ischemia Reperfusion Injury
Overview 8
Therapeutics Development 9
Pipeline Products for Ischemia
Reperfusion Injury - Overview 9
Pipeline Products for Ischemia
Reperfusion Injury - Comparative Analysis 10
Ischemia Reperfusion Injury -
Therapeutics under Development by Companies 11
Ischemia Reperfusion Injury -
Therapeutics under Investigation by Universities/Institutes 13
Ischemia Reperfusion Injury -
Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Ischemia Reperfusion Injury -
Products under Development by Companies 18
Ischemia Reperfusion Injury -
Products under Investigation by Universities/Institutes 20
Ischemia Reperfusion Injury -
Companies Involved in Therapeutics Development 22
Amyndas Pharmaceuticals LLC 22
Angion Biomedica Corp. 23
Biomedica Management
Corporation 24
Bolder Biotechnology, Inc. 25
Corline Biomedical AB 26
Curatis Pharma GmbH 27
Erimos Pharmaceuticals, LLC 28
Gilead Sciences, Inc. 29
Ischemix, Inc. 30
Kowa Company, Ltd. 31
LG Life Science LTD. 32
Omeros Corporation 33
Opsona Therapeutics Limited 34
Orexo AB 35
Pharming Group N.V. 36
PledPharma AB 37
Prolong Pharmaceuticals, LLC 38
Proteo, Inc. 39
Prothix BV 40
Recordati S.p.A. 41
Stealth BioTherapeutics Inc. 42
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment